Title:
HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/078461
Kind Code:
A1
Abstract:
A heterocyclic compound as shown in formula I, a tautomer, stereoisomer, solvate, pharmaceutically acceptable salt or prodrug thereof, a preparation method therefor, and the use thereof. The heterocyclic compound has a better 15-PGDH inhibitory effect.
Inventors:
ZHANG XUEJUN (CN)
LI XUEQIANG (CN)
WANG HONGQIANG (CN)
LI CHAO (CN)
LIU LIFEI (CN)
QIAN LINA (CN)
ZHAO XIN (CN)
LI LI'E (CN)
YANG JUN (CN)
LI XUEQIANG (CN)
WANG HONGQIANG (CN)
LI CHAO (CN)
LIU LIFEI (CN)
QIAN LINA (CN)
ZHAO XIN (CN)
LI LI'E (CN)
YANG JUN (CN)
Application Number:
PCT/CN2022/130676
Publication Date:
May 11, 2023
Filing Date:
November 08, 2022
Export Citation:
Assignee:
WUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY (CN)
International Classes:
C07D209/44; A61K31/4035; A61K31/4353; A61K31/5383; A61P9/00; A61P13/00; A61P17/00; A61P19/02; A61P27/16; A61P37/06; C07D211/38; C07D249/12; C07D401/14; C07D403/10; C07D413/14; C07D471/04; C07D498/04
Domestic Patent References:
| WO2020160151A1 | 2020-08-06 |
Foreign References:
| CN113226310A | 2021-08-06 | |||
| CN110573154A | 2019-12-13 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: